Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen plans to spin off hemophilia drug business into a public company
Biogen plans to spin off hemophilia drug business into a public company
Biogen plans to spin off hemophilia drug business into a public company
Submitted by
admin
on May 3, 2016 - 10:20am
Source:
Yahoo/Reuters
News Tags:
Biogen
spinoffs
hemophilia
Headline:
Biogen plans to spin off hemophilia drug business into a public company
Do Not Allow Advertisers to Use My Personal information
